On March 1, David B. Weiner, Ph.D., took the helm as executive vice president of the Wistar Institute and director of Wistar’s Vaccine Center. A pioneer in the development of DNA vaccines and immunotherapies, he has dedicated more than 30 years of cutting-edge work to the area of tumor immunology and vaccine research.
The Weiner lab finds its home on the sixth floor of the Robert and Penny Fox Tower—a state-of-the-art, open-plan research space where Dr. Weiner and his 20-person staff continue integral work on developing DNA vaccines for emerging infectious diseases and intractable cancers. The Weiner lab has had a hand in moving several discoveries into clinical trials, including phase 1 trials that are underway for cervical, head and neck, breast, lung, and pancreatic cancers as well as hepatitis B, hepatitis C, Ebola, and many more.
Dr. Weiner is igniting collaboration with many Wistar principal investigators to explore Zika virus, influenza, HIV, and combination therapies for ovarian, prostate, and other cancers. Having established national and global relationships between academia, industry, and government, Dr. Weiner’s work expands upon Wistar’s mission to create new treatments for the most uncompromising diseases and pushes the envelope of biomedical research by making lifesaving contributions to immunology, cancer biology and infectious diseases.